General Catalyst led a $65m Series C round in Redesign Health.

General Catalyst, an investment company, led a $65m Series C round in Redesign Health, a company which helps build, launch and find funding for digital health startups, with participation from CVS Health Ventures, UPMC Enterprises, Eden Global Partners, Euclidean Capital, Samsung Next, TriplePoint Capital and Declaration Partners. “We have a long way to go but through this process have developed a platform and a process that we think fundamentally changes the risk equation for innovation,” Brett Shaheen, Redesign CEO.